Dr Bhattacharya, Senior Endocrinologist, Official Website

S.Bhattacharya on April 19th, 2016 Comments Off on Dr Bhattacharya, Senior Endocrinologist, Official Website
Dr. S Bhattacharya, DM (AIIMS), MD (MAMC), Senior Consultant & Head, Max Patparganj, New Delhi

Dr. S Bhattacharya, DM (AIIMS), MD (MAMC), Senior Consultant, Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi

Dr. S Bhattacharya

MD Medicine (MAMC) DM Endocrinology (AIIMS),

FACE (Fellow American Association of Clinical Endocrinologists),

Specialty Certificate, Royal College of Physicians, UK,

Executive Committee Member, Endocrine Society of India

Ex- President, Society for Promotion of Education in Endocrinology & Diabetes (SPEED),

Guest Editor, Journal of Indian Medical Association (JIMA), Endocrinology Issue

Ex-HOD, Dept of Endocrinology, Max Hospital Patparganj, Delhi

Dr. Saptarshi Bhattacharya is an endocrinologist who deals with hormonal diseases like diabetes, thyroid disorders, PCOS, male sexual dysfunction, osteoporosis, etc.

Dr. Bhattacharya did his Masters in Medicine (MD) from Maulana Azad Medical College, New Delhi.

After that he specialized in Endocrinology (DM i.e. Doctorate in Medicine) from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi.

His primary focus is to provide holistic patient care to those suffering from diabetes, thyroid disorders and other hormonal problems. He has authored articles in international and national journals and is also actively involved in several research projects.

He is a Practising Endocrinologist at Sarita Vihar, South Delhi and Noida

Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi

eHealth Diabetes and Endocrinology Centre (eDEC), Noida

 

RESEARCH & PUBLICATIONS (*Pubmed indexed)

*1. Bhattacharya S, Ammini AC, Jyotsna V, Gupta N, Dwivedi S. Recovery of β-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patients. Diabetes Technol Ther. 2011;13:461-465

*2. Ammini AC, Bhattacharya S, Sahoo JP, Philip J, Tandon N, Goswami R, Jyotsna VJ, Khadgawat R, Chumber S, Seth A, Karak AK, Sharma BS, Chandra PS, Suri A, Sharma MS, Kale SS, Singh M. Cushing’s disease: results of treatment and factors affecting outcome. Hormones (Athens). 2011;10:222-229.

*3. Khandelwal D, Bhattacharya S, Gadodia A, Khadgawat R, Tandon N, Ammini AC. Metabolic bone disease as a presenting manifestation of primary Sjögren’s syndrome: Three cases and review of literature. Indian J Endocrinol Metab. 2011;15:341-345.

4. Bhattacharya S, Tandon N. Neuroendocrinology. In: Dhawan B.N, Seth P.K editors. Neurosciences in India 2009. Lucknow. Indian Academy of Neurosciences and central Scientific and Industrial Research; 2009. 355-64

*5. Chittawar S, Bhattacharya S, Sahoo J P, et al. Internal jugular vein: Peripheral vein adrenocorticotropic hormone ratio in patients with adrenocorticotropic hormone- dependent Cushing’s syndrome: Ratio calculated from one adrenocorticotropic hormone sample each from right and left internal jugular vein during corticotrophin releasing hormone stimulation test. Indian J Endocrinol Metab. 2013;17:128-32

*6. Khandelwal D, Bhattacharya S, Khadgawat R, Kaur S, Tandon N, Ammini AC. Hypokalemic paralysis as a presenting manifestation of primary Sjögren’s syndrome: A report of two cases. Indian J Endocr Metab 2012;16:853-5

*7. Surana V, Aggarwal S, Khandelwal D, Singla R, Bhattacharya S, Chittawar S, Kalra S, Dutta D; Society for Promotion of Education in Endocrinology and Diabetes Group, India. A 2016 clinical practice pattern in the management of primary hypothyroidism among doctors from different clinical specialties in New Delhi. Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):165-177

8. Bhattacharya S, Sachdeva M; An unusual cause of hypoglycemia in a child with Acute Lymphoblastic Leukemia. Endocrine Practice. 2017: 23 (Suppl): 88

9. Bhattacharya S, Khadgawat R, Ammini A C, Grewal E, Gupta A, Seth A, Gadodia A. Cherubism or craniofacial fibrous dysplasia? A diagnostic dilemma! Horm Res 2008;70(suppl 3):28

10. Surana V, Singla R, Aggarwal S, Khandelwal D, Bhattacharya S, Kalra S, Dutta D. Short Stature – Clinical Approach to Diagnosis: A 2018 Perspective. J Indian Med Assoc. 2018; 116: 56-62

11. Dutta P, Gupta G, Singla R, Kantroo V, Bandyopadhyay D, Dutta D, Bhattacharya S. Artificial Sweeteners: Clinical Perspective. J Indian Med Assoc. 2018; 116: 67-71

12. Rosha R, Bhattacharya S, Aggarwal S, Singla R. Type 2 Diabetes Reversal in India: Is a Low Carbohydrate Diet Practical and Sustaianable. J Indian Med Assoc. 2018; 116: 85-88

13. Bhattacharya S, Adhikary AK, Mondal S, Bandyopadhyay D. SGLT2 Inhibitors and Cardiovascular Outcomes: Inferences for Clinical Practice. J Indian Med Assoc. 2018;116: 89-92

14. Dutta D, Khandelwal D, Chittawar S, Aggarwa S, Bhattacharya S, Surana V, Singla R, Kalra S. Bone Health Clinical Practice in India— Concern Regarding Vitamin D Toxicity. US Endocrinology. 2018;14(2):87–92

15. Bhattacharya S. Hypothyroidism during pregnancy. In: Aggarwal S, Kalra S editors. Pregnancy and thyroid disorders. Evangel 2018.

16. Dutta D, Shrestha D, Khandelwal D, Baruah M, Kalra S, Agarwal S, Bhattacharya S, Singla R, Surana V. A 2018 clinical practice pattern in the management of diabetes in India and Nepal: a three-city study. Int J Diabetes Dev Ctries. 2019; 39:557–567. doi: 10.1007/s13410-018-0701-7

17. Bhattacharya S, Malhotra R. Combination of SGLT 2 inhibitors and DPP4 inhibitors. In: Aggarwal S, Kalra S editors. SGLT 2 Inhibitors: Clinical manual. Evangel 2019.

*18. Kalra S, Das AK, Sahay RK, Baruah MP, Tiwaskar M, Das S, Chatterjee S, Saboo B, Bantwal G, Bhattacharya S, et al. Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force. Diabetes Ther. 2019 Jul 29. doi: 10.1007/s13300-019-0669-4.

19. Arora B, Gupta L, Khandelwal D, Bhattacharya S, Kalra S, Chittawar S, et al. Knowledge, attitude, and practices of fasts in patients with type 2 diabetes among different religions in North India. Int J Diabetes Dev Ctries. 2019; doi: 10.1007/s13410-019-00760-z

20. Bhattacharya S, Sehgal A, Kalra S. All Thyrotoxicosis is not Graves’ Disease. J Indian Med Assoc. 2019; 117: 18-20

*21. Bhattacharya S, Kalra S, Dutta D, Khandelwal D, Singla R. The Interplay Between Pituitary Health and Diabetes Mellitus – The Need for ‘Hypophyseo-Vigilance’. Eur Endocrinol. 2020;16(1):25-31. doi:10.17925/EE.2020.16.1.25

*22. Dutta D, Sharma M, Aggarwal S, Mohindra R, Bhattacharya S, Kalra S. Vitamin D, thyroid autoimmunity and cancer: An interplay of different factors. Indian J Endocr Metab 2019;23:507-13

23. Arora B, Gupta L, Khandelwal D, Bhattacharya S, Kalra S, Chittawar S, et al. Knowledge, attitude, and practices of fasts in patients with type 2 diabetes among different religions in North India. Int. J. Diabetes Dev. Ctries. 2019; 10.1007/s13410-019- 00760-z.

24. Goyal A, Bhattacharya S, Shahjada S. Endocrine Syndromes in Diabetes. In: Kalra S, Priya G. Glucocrinology: The Relationship between Glucose and Endocrine Function. Jaypee Brothers, 2019.

25. Krishnamurthy A, Bhattacharya S. Classification of Insulin Regimens. In: Aggarwal S, Kalra S editors. Insulin Manual. Evangel 2020.

26. Kantroo V, Bhattacharya S. Insulin in Critical Care. In: Aggarwal S, Kalra S editors. Insulin Manual. Evangel 2020.

*27. Kalra S, Bhattacharya S, Joshi A. Osteocrinology. Osteoporos Int. 2020. https://doi.org/10.1007/s00198-020-05288-1

*28. Bhattacharya S, Goyal A, Kaur P, Singh R, Kalra S. Anticancer Drug-induced Thyroid Dysfunction. Eur Endocrinol. 2020;16(1):32-39. doi:10.17925/EE.2020.16.1.32

29. Gupta L, Arora B, Khandelwal D, Lal PR, Kalra S, Bhattacharya S, et al. Dietary practices during common religious fasts in people with type 2 diabetes mellitus among different religions in north India – A questionnaire based study. US Endocrinology. 2020;16(1): Epub ahead of publication

*30. Kalra S, Priya G, Bhattacharya S, Sahay R. Oncocrinology. J Pak Med Assoc. 2020 Apr;70(4):757-761.

*31. Kalra S, Iraqi H, Sahay R, Bhattacharya S. The glycaemic personality: A SURE framework of person-centred choice in diabetes care. J Pak Med Assoc. 2020 Apr;70(7):1285-1286.

*32. Bhattacharya S, Krishnamurthy A, Gopalakrishnan M, Kalra S, Kantroo V, Aggarwal S, Surana V. Endocrine and Metabolic Manifestations of Snakebite Envenoming. Am J Trop Med Hyg. 2020 Oct;103(4):1388-1396. doi: 10.4269/ajtmh.20-0161. PMID:32602439; PMCID: PMC7543852.

33. Lakhani O, Shaikh A, Krishnamurthy A, Bhograj, Patil, Shenoy, Bhattacharya S, Somani, Lathia T (2020). FREQUENTLY ASKED QUESTIONS ON USING TELEMEDICINE BY ENDOCRINOLOGISTS IN INDIA. 10.13140/RG.2.2.12274.04808.

34. Lakhani OJ, Lathia T, Bhattacharya S, Shaikh A. “Telethyroidology”: Managing thyroid disorders through telemedicine. Thyroid Res Pract. 2020;17:56-61

*35. Bhattacharya S, Kalra S. Quinary Prevention and Bariatric surgery. J Pak Med Assoc. 2020 Sep;70(9):1664-1666. PMID: 33040136.

*36. Krishnamurthy A, Bhattacharya S, Lathia T, Kantroo V, Kalra S, Dutta D. Anticancer Medications and Sodium Dysmetabolism. Eur Endocrinol. 2020 Oct;16(2):122-130. doi: 10.17925/EE.2020.16.2.122. Epub 2020 Oct 6. PMID: 33117443; PMCID: PMC7572166.

*37. Kalra S, Bhattacharya S, Kalhan A. Testosterone in COVID-19 – Foe, Friend or Fatal Victim? Eur Endocrinol. 2020 Oct;16(2):88-91. doi: 10.17925/EE.2020.16.2.88. Epub 2020 Oct 6. PMID: 33117437; PMCID: PMC7572157.

*38. Dutta D, Bhattacharya S, Surana V, Aggarwal S, Singla R, Khandelwal D, Sharma M. Efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis. Diabetes Metab Syndr. 2020 Sep 6;14(6):1759-1768. doi: 10.1016/j.dsx.2020.08.039. Epub ahead of print. PMID: 32937280.

*39. Dutta D, Bhattacharya S, Surana V, Aggarwal S, Singla R, Khandelwal D, Sharma M. Response to the letter to the editor submitted by Jaiswal A et al. (2020) regarding ‘efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta- analysis’ (Dutta et al.). 2020 Oct 29;14(6):2093. doi: 10.1016/j.dsx.2020.10.027.

*40. Dutta D, Bhattacharya S, Krishnamurthy A, Sharma LK, Sharma M. Efficacy and safety of novel dipeptidyl-peptidase-4 inhibitor evogliptin in the management of type 2 diabetes mellitus: A meta-analysis. Indian J Endocr Metab 2020;24:434-45.

*41. Kalra S, Singla R, Dhawan M, Bhattacharya S, Aggarwal S. The Islet De-stress Hypothesis: A potential explanation for the gluco-metabolic effects of ketogenic diet. J Pak Med Assoc. 2020;70(12):2285-2288.

*42. Kalra B, Kalra S, Bhattacharya S, Dhingra A. Menopause distress: A person centered definition. J Pak Med Assoc. 2020;70(12-B):2481-2482.

*43. Kalra S, Kapoor N, Bhattacharya S, Aydin H, Coetzee A. Barocrinology: The Endocrinology of Obesity from Bench to Bedside. Med. Sci. 2020, 8, 51.

*44. Dutta D, Bhattacharya S, Sharma M. et al. Effect of yoga on glycemia and lipid parameters in type-2 diabetes: a meta-analysis. J Diabetes Metab Disord. 2021. DOI: 10.1007/s40200-021-00751-0

*45. Kantroo V, Bhattacharya S, Dhingra A, Kalra S. Pulmocrinology: Interplay of pulmonary and endocrine diseases. J Pak Med Assoc. 2021;71(3):1033-1038.

*46. Kalra S, Dhingra A, Sharma SK, Bhattacharya S. Sheehan’s syndrome as a mimic of premature ovarian insufficiency: need for advocacy, Climacteric, 2021. DOI: 10.1080/13697137.2021.1905626

*47. Kapoor N, Sahay R, Kalra S, Bajaj S, Dasgupta A, Shrestha D, Dhakal G, Tiwaskar M, Sahay M, Somasundaram N, Reddy R, Bhattacharya S, Reddy VB, Viswanathan V, Krishnan D, Baruah M, Das AK. Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in Adults: A South Asian Perspective. Diabetes Metab Syndr Obes. 2021;14:1703-1728. DOI: 10.2147/DMSO.S278928

*48. Kalra S, Bhattacharya S, Mittal R. The diabetic muscle. J Pak Med Assoc. 2021;71(5):1503-1505

*49. Kalra S, Bhattacharya S. Metabolic optimization in diabetes: A hierarchial model. J Pak Med Assoc. 2021;71(5):1506-1507

*50. Kalra S, Bhattacharya S, Rawal P. Hepatocrinology. Med Sci (Basel). 2021 Jun 1;9(2):39. doi: 10.3390/medsci9020039.

*51. Kalra S, Bhattacharya S, Kapoor N. Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs). Diabetes Ther. 2021 Jul 15. doi: 10.1007/s13300- 021-01113-y. Epub ahead of print. PMID: 34268675.

*52. Bhattacharya S, Kubihal S, Tyagi P. Fungi and Endocrine Dysfunction. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; June 25, 2021.

*53. Bhattacharya S, Nagendra L, Krishnamurthy A, Lakhani OJ, Kapoor N, Kalra B, Kalra S. Early Gestational Diabetes Mellitus: Diagnostic Strategies and Clinical Implications. Med Sci. 2021; 9(4):59. https://doi.org/10.3390/medsci9040059

*54. Bhattacharya S, Kalra S, Kapoor N, Singla R, Dutta D, Aggarwal S, Khandelwal D, Surana V, Dhingra A, Kantroo V, Chittawar S, Deka N, Bindal V, Dutta P. Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery. World J Diabetes 2021; 12(10): 1587-1621 [DOI: 10.4239/wjd.v12.i10.1587]

Comments are closed.